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Abstract
Based on the largest data set ever available for analysis of heart rate variability
(HRV) variables, in healthy individuals, it was possible to determine the evolution-
ary behavior of three representative components of parasympathetic nervous sys-
tem function (RMSSD, PNN50, and HF ms2), in different age groups of the life
cycle: newborns, children and adolescents, young adults, and, finally, middle-aged
adults. A near-parabolic and nonsynchronous behavior was observed among the
different variables evaluated, with low values at first, then progressive elevation,
and later fall, approximating the values of the newborns to the values of middle-
aged adults and suggesting that the autonomic nervous system, at least relatively to
its parasympathetic component, undergoes a growing maturation that is completed
in the young adult and later suffers a progressive degeneration, completing the life
cycle. This fact should be considered when comparing the analysis between healthy
individuals and those with different states of pathological impairment.
Keywords: autonomic nervous system, parasympathetic nervous system, heart rate
variability, homeostasis, life cycle
1. Introduction
The autonomic nervous system (ANS) is a division of the peripheral nervous
system and, based on anatomy and physiology, has three subdivisions: sympathetic
nervous system (SNS), parasympathetic nervous system (PNS), and enteric ner-
vous system (ENS). SNS has thoracolumbar distribution, and PNS has a craniosacral
distribution, while ENS is the major part of the peripheral nervous system being
found throughout the gastrointestinal tract, extending from the esophagus to the
rectum, and is also present in the pancreas and in the gallbladder [1–4].
ANS has the responsibility to ensure that homeostasis be maintained in the face
of disturbances produced by both the external and internal environment [5]. In the
heart of rats, ANS begins its development on the embryonic 18.5 day until the
twenty-first postnatal day (P21) [6].
Sympathetic neurons are located in the paravertebral ganglia, have long axonal
projections to the organs, and produce excitatory effects mediated by the norad-
renergic transmitter norepinephrine (NE). Conversely, parasympathetic neurons
are located in ganglia near or on the surface of organs, have shorter axonal pro-
jections, and produce inhibitory effects mediated by the cholinergic transmitter
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acetylcholine (ACh). The enteric nervous system provides the intrinsic innervation
of the gut, controlling different aspects of the gut function, such as motility [4].
Although ANS can actually function autonomously, the central nervous system
can contribute to a significant regulatory effect [3].
Heart rate variability (HRV) analysis is a practical, noninvasive, reproducible,
and cost-effective resource that has been widely applied to study the autonomic
behavior of the human organism, being particularly useful for the evaluation of
sympathetic and parasympathetic components, although with regard to sympa-
thetic behavior, there is still controversy about the mechanisms involved [7].
Higher vagally mediated heart rate variability is associated with better auto-
nomic balance, better health outcomes, and flexible physiological responses. In
contrast, lower HRV is associated with disease and all-cause mortality [8].
In [9], some reference values for normality of HRV variables are suggested,
although highlighting that “As no comprehensive investigations of all HRV indices
in large normal populations have yet been performed, some of the normal values
[…] were obtained from studies involving small number of subjects.”
The reference values for normality cited and recommended in the Task Force
were taken from the work of Bigger et al. (1995). The authors were based on only
274 individuals considered healthy and restricted to be 40–69 years old [10].
The aim of this chapter is restricted to the parasympathetic division of ANS. For
the evaluation of this component, there is a well-established consensus that some
variables, such as the root mean square of the successive RR interval differences
(RMSSD), the percent of normal RR intervals that differed by more than 50 ms
(PNN50) both in the time domain, and the absolute power of the high-frequency
band component (HF ms2), in the frequency domain, specifically represent vagal
modulation, presenting both diagnostic and prognostic properties [11–12].
Generally speaking, heart rate variability analysis has become the most used
noninvasive tool to evaluate autonomic control mechanisms and to predict mortal-
ity risk in several clinical conditions, including coronary artery disease, heart fail-
ure, diabetes, and hypertension [13].
According to Goldberger et al. [14], there was some evidence that age influenced
the responsiveness of the HRV parameters with changing parasympathetic effect.
They studied 29 normal volunteers (15 women; mean age 39  12 years) after β-
adrenergic blockade with intravenous propranolol. Five-minute ECG recordings
were made during graded infusions of phenylephrine and nitroprusside to achieve
baroreflex-mediated increases and decreases in parasympathetic effect, respec-
tively. There was some evidence that age influenced the responsiveness of the HRV
parameters with changing parasympathetic effect, with significant association for
RMSSD and PNN50.
Despite the significant amount of studies in the literature dealing with the HRV
and autonomic regulation subject, there is a lack of studies with large series,
addressing several variables in different age ranges, from birth to the elderly adult.
So, we will evaluate the contribution of these three variables in the study of para-
sympathetic autonomic behavior throughout the life cycle based on the evaluation
of a significant amount of data (835,902 in total) extracted from the literature
regarding heart rate variability variables and admittedly related to the parasympa-
thetic nervous system being 53,882 results from healthy individuals.
2. Method
The inclusion criterion was quite broad in view of the proposed objective, which
was to establish reference values, based on the largest amount of information
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possible. Thus, by searching the available databases (PubMed, Google Scholar,
Cochrane Library, ScienceDirect, Wiley Online Library, SciELO, LILACS, and The-
sis Banks of Brazilian Universities, among others) and following the PRISMA 2009
flow diagram [15], articles evaluating the values of heart rate variability (Flow
Diagram) were included, and after, those directly related to the parasympathetic
component of ANS, in the time domains (RMSSD and PNN50) and in the frequency
domain (HF ms2), in humans, regardless of age and gender and also regardless of
the length of the time series, patient position, and analysis equipment, were selected
but provided that the data were always collected from individuals specifically con-
sidered to be healthy. Based on this criterion, it is noteworthy that the individuals,
who in the original work were cataloged as being from the general population, were
not considered to be healthy because there are known comorbidities in this type of
sample, and so, they were not included.
Values with evident evidence of extreme outliers (three or more standard devi-
ations below the first quartile or above the third quartile, from the set of values
collected for a given variable) were excluded.
Flow diagram
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Table 1 informs the studied variable, its domain, and the amount of values
collected in the literature.
RMSSD (root mean square of the successive RR intervals differences, in ms;
PNN50 (percent of normal RR intervals that differed by more than 50 ms in %); HF
(absolute power of the high-frequency band; 0.15–0.40 Hz, in ms2).
Groupings were made by age range to precisely characterize the evolutionary
behavior of the parasympathetic system throughout the life cycle. The amounts of
data evaluated for each group and their average ages and standard deviations are
shown in Table 2.
From all included studies, the mean and the standard deviation values of each
variable of interest were extracted. The overall mean value was obtained by
weighted average. The global standard deviation was obtained from the individual
mean set of each study. As the collected values were the means and standard
deviations, the existence of normality was assumed. The values from the different
age groups were compared with the aid of the unpaired t-test assuming that the
standard deviations of each group were not similar to each other (Welch correc-
tion). GraphPad InStat version 3.00 software was used to obtain P-values. A PDF
file containing all the 335 references used to mounting the database can be solicited
to the correspondent author. The large number of references would make it impos-
sible to include them directly in the present text.
3. Results
Table 3 summarizes the results obtained.
RMSSD (root mean square of the successive RR intervals differences in ms;
PNN50 (percent of normal RR intervals that differed by more than 50 ms), HF
(absolute power of the high-frequency band; 0.15–0.40 Hz); SD, standard deviation.
Domain Variable Total group General population + diseased Healthy
Time RMSSD ms 208,657 183,155 25,502
Time PNN50 49,400 35,043 14,357
Frequency HF ms2 159,894 145,871 14,023
Table 1.
Distribution of the literature data evaluated, in terms of the variable studied, highlighting the sample of interest
(healthy individuals) and its size in relation to the total amount obtained.
Age range (years) Age mean  SD RMSSD (ms) PNN50 (%) HF(ms2)
Newborns [0 a 3 days] 234 78 272
Up to 20 13.29  4.64 4,419 2,790 4,346
20–40 25.21  4.88 8,459 1,031 5,721
40–70 52.74  7.56 12,390 10,468 3,684
Totals 25,502 14,357 14,023
Table 2.
Mean and standard deviation of the analyzed age groups and respective amounts of data analyzed, by studied
variable..
4
Autonomic Nervous System Monitoring - Heart Rate Variability
The statistical analysis (p-values, t-test unpaired, two-tailed, Welch correction)
comparing the mean values for each variable along the age ranges is showed below.
As can be observed, the P-values were extremely robust indicating significant
extreme differences for all comparisons.
Figures were constructed showing the behavior of each variable along the pro-
gressive increase in chronological age, from the healthy newborn group (subgroup 1)
to children and adolescents (subgroup 2) and young adults (subgroup 3), until
reaching the middle-aged adults (subgroup 4).
Figures 1–3 graphically demonstrate this behavior.
Group Age range RMSSD PNN50 HF
Mean  SD Mean  SD Mean  SD
1 Newborns 11.6  0.9 1.4  3.7 66.7  85.5
2 Up to 20 52.0  18.0 25.7  11.6 1124.0  710.8
3 20–40 53.1  22.2 19.9  12.9 2067.2  1144.7
4 40–70 28.2  11.8 6.9  0.3 236.3  248.5
Table 3.
Mean and standard deviation of the variables studied according to the different age groups.
Group RMSSD PNN50 HF
1 versus 2 P < 0.0001 P < 0.0001 P < 0.0001
1 versus 3 P < 0.0001 P < 0.0001 P < 0.0001
1 versus 4 P < 0.0001 P < 0.0001 P < 0.0001
2 versus 3 P = 0.0024 P < 0.0001 P < 0.0001
2 versus 4 P < 0.0001 P < 0.0001 P < 0.0001
3 versus 4 P < 0.0001 P < 0.0001 P < 0.0001
Figure 1.
Mean evolutionary behavior of RMSSS values for the different age groups studied. RMSSD (root mean square of
the successive RR interval differences in ms; 1, healthy newborns subgroup; 2, children and adolescents (up to
20 years) subgroup; 3, young adults (20–40 years) subgroup; 4, middle-aged adults (40–70 years) subgroup.
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4. Discussion
It is well known that the heart rate variability declines with age. Bonnemeier
et al. (2003) [16] obtained 24h recordings from 166 healthy volunteers (85 men and
81 women) aged 20–70 years. They found the most dramatic HRV parameter
decrease between the second and third decades. Almeida-Santos et al. (2016) [17]
obtained 24h ECG recordings of 1743 subjects of 40–100years of age. They found a
linear decline in SDNN, SDANN, and SDNN index. Curiously, they described U-
shaped pattern for RMSSD and pNN50 with aging, decreasing from 40 to 60 and
then increasing after age 70.
The present study adds new information about this evolutionary behavior. It
was quite clear that parasympathetic autonomic development in healthy individuals
is peculiar, being reduced at birth, presenting a progressive elevation up to about
20 years of age (for the three variables studied), and typically, after that initial
elevation, two different patterns of behavior occur. The RMSSD variable arises a
little more until around 40 years of age when it then begins to decline progressively
(Figure 1), which we might call as a “‘negatively skewed tent’ behavior.” The
PNN50 variable, once reaching its maximum levels around the age of 20, begins to
Figure 2.
Mean evolutionary behavior of PNN50 values for the different age groups studied.PNN50% ((percent of
normal R-R intervals that differed by more than 50 ms); 1, healthy newborns subgroup; 2, children and
adolescents (up to 20 years) subgroup; 3, young adults (20–40 years) subgroup; 4, middle-aged adults
(40–70 years) subgroup.
Figure 3.
Mean evolutionary behavior of HF ms2 values for the different age groups studied. HF ms2 (absolute power of
the high-frequency band; 0.15–0.40 Hz); 1, healthy newborns subgroup; 2, children and adolescents (up to
20 years) subgroup; 3: Young adults (20–40 years) subgroup; 4, middle-aged adults (40–70 years) subgroup.
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decline progressively until the age of 70 (Figure 2), which would graphically be a
“positively skewed tent” behavior. Finally, the HF variable rises from birth to about
40 years, when it begins to decline until 70 years of age being graphically a “nega-
tively skewed tent” behavior (Figure 3).
We did not find significant studies on heart rate variability in healthy individ-
uals over 70s, probably because above that age, the vast majority of the individuals
already have some pathological impairment. Yes, it would exist for the general
population, but that was not the focus at this moment. Therefore, a complete
definition of HRV behavior in that older group, based on a significant sample like
that used here for the other age groups, was not yet possible.
The significant amount of data obtained, together with the extremely significant
difference between the values in the different age groups, strongly indicates that
this was not a casual finding but a true expression of parasympathetic autonomic
behavior.
This is a relevant finding as it sheds new light on the knowledge of normal values
in different age groups, since the current gold standard is still established by the
Task Force data, based on only 274 cases and exclusively on the age range of
40–69 years.
5. Conclusion
Like every other complex system, in accordance with Chaos Theory, ANS, at
least in its parasympathetic component, exhibits a near-parabolic and
nonsynchronous behavior for the main variables that evaluates it using heart rate
variability, and this fact should be considered in the comparative analysis between
healthy individuals and those with different grades of pathological impairment.
Based on the largest data set ever available for healthy individuals, the found
values can be proposed as reference standards for future studies about heart rate
variability.
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